Minimal residual disease assessment in acute myeloid leukemia by molecular techniques: Recent advances
Journal Title: Αρχεία Ελληνικής Ιατρικής - Year 2012, Vol 29, Issue 1
Abstract
In recent years a number of gene mutations (Flt-3, NPM1, CEBPA, MLL, N-RAS, RUNX1, WT-1, IDH) and deregulated expression of genes (WT-1, EVI1, PRAME, BAALC, ERG, MN-1) have been identified, illustrating the enormous heterogeneity of cytogenetically defined subsets of acute myeloid leukemia (AML), in particular in the large subset of cytogenetically normal (CN) AML. Monitoring of the minimal residual disease (MRD) in AML patients is now recognized to be an important diagnostic tool that can be used to assess the response to treatment and to establish the risk of relapse in the individual patient. The most recent techniques, based principally on immunophenotyping by multiparametric flow cytometry (MFC) or real time-quantitative polymerase chain reaction (RQ-PCR) analysis, have in most instances the sensitivity to detect at least one leukemic cell out of 104 background cells. Standardized RQ-PCR procedures for the most common types of fusion transcripts present in AML (i.e., PML/RARα, AML1/ETO and CBFB/MYH11, representing about 30% of all AML cases) have now been developed, permitting large scale MRD studies. In addition, a reliable and highly sensitive RQ-PCR test can be performed in almost 90% of patients with NPM1 mutations (about 35−40% of all AML cases). Finally, RQ-PCR assessment of the disease level is, through the use of WT-1 overexpression, now feasible in more than 70% of AML patients.
Authors and Affiliations
I. KAKKAS
Plasmodium knowlesi malarial infection in western travelers returning from Southeast Asia. A summary of the clinical pattern
OBJECTIVE Knowlesi malaria is a new, important and potentially lethal mosquito-borne disease in the tropical countries, caused by infection with Plasmodium knowlesi. Southeast Asia is the region with the highest prevalen...
Primary angiosarcoma of the lung-pleura
No abstract available
Calcium-alkali syndrome
No abstract available
Μελέτη ALLHAT<br /> Η μεγαλύτερη μέχρι σήμερα μελέτη παρέμβασης στην υπέρταση απαντά<br /> στο ερώτημα ποιο είναι το καλύτερο αντιυπερτασικό φάρμακο<br />
Role of research in mycology in the introduction of fungal infection determinants
In recent years a multitude of molecular and immuno-serological methods have been introduced in the field of diagnostic mycology. Rapid developments in the area referred to as "molecular diagnosis of fungal diseases", ge...